" class="no-js "lang="en-US"> Elekta - Medtech Alert
Friday, June 21, 2024
Elekta | Pharmtech Focus

Elekta

About Elekta

Elekta

At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it’s personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.

Related Story

Elekta to Appoint Tobias Hägglöv as Chief Financial Officer

January 7 2022

Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer […]

More Cancer Patients in Africa to Benefit from Advanced Radiation Therapy with Elekta Unity MR-Linac

November 25 2021

Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less […]